Barclays PLC Barclays Pillar 3 Disclosures: Terms and Conditions of Capital Resources Return to stability Supplement to Barclays 2015 Pillar 3 Report Introductory notes This worksheet complements the 2015 Barclays Pillar 3 report, available from barclays.com/annualreport. It contains detailed information on the terms and conditions of capital resources in accordance with Article 437 (1)(b) of the CRR and the associated implementing technical standards. Please see table 8 page 20 for summarised information. The full prospectus associated with each instrument can be found at the following sites barclays.com/prospectuses-and-documentation/capital- securities-documentation.html, barclaysafrica.com/barclaysafrica/Investor-Relations/Debt-investors/Debt-programmes, absa.co.za/Absacoza/About-Absa/Absa-Bank/Debt-Investors/Domestic-Medium-Term-Notes, home.barclays/about- barclays/barclays-corporate-governance/our-framework-code-and-rules.html and barclaysafrica.com/deployedfiles/Assets/Richmedia/PDF/Reports/2012/2012_Notice_of_AGM.pdf The Capital Requirements Regulation and Capital Requirements Directive implemented Basel 3 within the EU (collectively known as CRD IV) on 1 January 2014. The rules are supplemented by Regulatory Technical Standards and the PRA’s rulebook, including the implementation of transitional rules. However, rules and guidance are still subject to change as certain aspects of CRD IV are dependent on final technical standards and clarifications to be issued by the EBA and adopted by the European Commission and the PRA. Assumptions on the regulatory treatment under the CRR reflect Barclays’ interpretation of the current rules. Forward-looking statements This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Examples of forward-looking statements include, among others, statements regarding the Group’s future financial position, income growth, assets, impairment charges and provisions, business strategy, capital, leverage and other regulatory ratios, payment of dividends (including dividend pay-out ratios), projected levels of growth in the banking and financial markets, projected costs or savings, original and revised commitments and targets in connection with the strategic cost programme and the Group Strategy Update, run-down of assets and businesses within Barclays Non-Core, estimates of capital expenditures and plans and objectives for future operations, projected employee numbers and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. These may be affected by changes in legislation, the development of standards and interpretations under International Financial Reporting Standards, evolving practices with regard to the interpretation and application of accounting and regulatory standards, the outcome of current and future legal proceedings and regulatory investigations, future levels of conduct provisions, the policies and actions of governmental and regulatory authorities, geopolitical risks and the impact of competition. In addition, factors including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules (including with regard to the future structure of the Group) applicable to past, current and future periods; UK, US, Africa, Eurozone and global macroeconomic and business conditions; the effects of continued volatility in credit markets; market related risks such as changes in interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in capital markets; changes in credit ratings of any entities within the Group or any securities issued by such entities; the potential for one or more countries exiting the Eurozone; the implementation of the strategic cost programme; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the Group’s control. As a result, the Group’s actual future results, dividend payments, and capital and leverage ratios may differ materially from the plans, goals, and expectations set forth in the Group’s forward-looking statements. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in our filings with the SEC (including, without limitation, our Annual Report on Form 20-F for the fiscal year ended 31 December 2015), which are available on the SEC’s website at www.sec.gov. Subject to our obligations under the applicable laws and regulations of the United Kingdom and the United States in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward looking statements, whether as a result of new information, future events or otherwise. barclays.com/annualreport Barclays Pillar 3 disclosure - Terms and Conditions of Capital Resources I 1 Capital instruments main features template 1 Issuer Barclays PLC 2 Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement) GB0031348658 3 Governing law(s) of the instrument United Kingdom Regulatory treatment 4 Transitional CRR rules Common Equity Tier 1 5 Post-transitional CRR rules Common Equity Tier 1 6 Eligible at solo/(sub-)consolidated/ solo&(sub-)consolidated Consolidated 7 Instrument type (types to be specified by each jurisdiction) Ordinary Shares 8 Amount recognised in regulatory capital (Currency in million, as of most recent reporting date) £21586m 9 Nominal amount of instrument £0.25 per ordinary share 9a Issue price The original authorised share capital at 20 July 1896 was £6,000,000 divided into 300,000 shares of £20 each. On 23 July 1896 250,000 ordinary shares of £20 each were issued, having £8 per share paid up. However, there have been many restructurings since then and the shares have been issued at other prices over time 9b Redemption price N/A 10 Accounting classification Shareholder's equity 11 Original date of issuance 23/07/1896 12 Perpetual or dated Perpetual 13 Original maturity date No maturity 14 Issuer call subject to prior supervisory approval N/A 15 Optional call date, contingent call dates and redemption amount N/A 16 Subsequent call dates, if applicable N/A Coupons / dividends 17 Fixed or floating dividend/coupon Floating 18 Coupon rate and any related index N/A 19 Existence of a dividend stopper No - However, please note that if any preference dividend is not paid in full on the relevant dividend payment date a dividend restriction shall apply to these ordinary shares 20a Fully discretionary, partially discretionary or mandatory (in terms of timing) Fully discretionary 20b Fully discretionary, partially discretionary or mandatory (in terms of amount) Fully discretionary 21 Existence of step up or other incentive to redeem N/A 22 Noncumulative or cumulative Noncumulative 23 Convertible or non-convertible Non-convertible 24 If convertible, conversion trigger(s) N/A 25 If convertible, fully or partially N/A 26 If convertible, conversion rate N/A 27 If convertible, mandatory or optional conversion N/A 28 If convertible, specify instrument type convertible into N/A 29 If convertible, specify issuer of instrument it converts into N/A 30 Write-down features No 31 If write-down, write-down trigger(s) N/A 32 If write-down, full or partial N/A 33 If write-down, permanent or temporary N/A 34 If temporary write-down, description of write-up mechanism N/A 35 Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument) Perpetual Deeply Subordinated Contingent Convertible Debt 36 Non-compliant transitioned features No 37 If yes, specify non-compliant features N/A barclays.com/annualreport Barclays Pillar 3 disclosure - Terms and Conditions of Capital Resources I 2 Capital instruments main features template 1 Issuer Barclays Africa Group Limited 2 Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement) ZAE000174124 3 Governing law(s) of the instrument Section 1 of the Banks Act, 1990 (Act no 94. of 1990) (As amended) Regulatory treatment 4 Transitional CRR rules Common Equity Tier 1 5 Post-transitional CRR rules Common Equity Tier 1 6 Eligible at solo/(sub-)consolidated/ solo&(sub-)consolidated Consolidated 7 Instrument type (types to be specified by each jurisdiction) Ordinary Shares 8 Amount recognised in regulatory capital (Currency in million, as of most recent reporting date) ZAR 5941m; £257m 9 Nominal amount of instrument ZAR 2.00; £0.09 per ordinary share 9a Issue price Absa Group Limited issued 129,540,636 Consideration Shares to Barclays Plc at a share price of ZAR 141.5; £6.12 at the point the Absa Group was renamed Barclays Africa Group Limited, since then the shares have been issued at other prices over time 9b Redemption price N/A 10 Accounting classification Non-controlling interest in consolidated subsidiary 11 Original date of issuance 2013 12 Perpetual or dated Perpetual 13 Original maturity date No maturity 14 Issuer call subject to prior supervisory approval N/A 15 Optional call date, contingent call dates and redemption amount N/A 16 Subsequent call dates, if applicable N/A Coupons / dividends 17 Fixed or floating dividend/coupon Floating 18 Coupon rate and any related index N/A 19 Existence of a dividend stopper No 20a Fully discretionary, partially discretionary or mandatory (in terms of timing) Fully discretionary 20b Fully discretionary, partially discretionary or mandatory (in terms of amount) Fully discretionary 21 Existence of step up or other incentive to redeem N/A 22 Noncumulative or cumulative Noncumulative 23 Convertible or non-convertible Non-convertible 24 If convertible, conversion trigger(s) N/A 25 If convertible, fully or partially N/A 26 If convertible, conversion rate N/A 27 If convertible, mandatory or optional conversion N/A 28 If convertible, specify instrument type convertible into N/A 29 If convertible, specify issuer of instrument it converts into N/A 30 Write-down features No 31 If write-down, write-down trigger(s) N/A 32 If write-down, full or partial N/A 33 If write-down, permanent or temporary N/A 34 If temporary write-down, description of write-up mechanism N/A 35 Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument) Perpetual Deeply Subordinated Contingent Convertible Debt 36 Non-compliant transitioned features No 37 If yes, specify non-compliant features N/A barclays.com/annualreport Barclays Pillar 3 disclosure - Terms and Conditions of Capital Resources I 3 Capital instruments main features template 1 Issuer Barclays PLC 2 Unique identifier (eg CUSIP, ISIN or Bloomberg identifier for private placement) US06738EAA38 3 Governing law(s) of the instrument New York, except subordination provisions and waiver of set-off provisions which are governed by English law Regulatory treatment 4 Transitional CRR rules Additional Tier 1 5 Post-transitional CRR rules Additional Tier 1 6 Eligible at solo/(sub-)consolidated/ solo&(sub-)consolidated Consolidated 7 Instrument type (types to be specified by each jurisdiction) Perpetual Deeply Subordinated Contingent Convertible Debt 8 Amount recognised in regulatory capital (Currency in million, as of most recent reporting date) £1229m 9 Nominal amount of instrument USD 2000m; £1350m 9a Issue price 99.993% 9b Redemption price 100.000% 10 Accounting classification Shareholders' equity 11 Original date of issuance 20/11/2013 12 Perpetual or dated Perpetual 13 Original maturity date No maturity 14 Issuer call subject to prior supervisory approval Yes 15 Optional call date, contingent call dates and redemption amount Optional call on 15/12/2018 at 100%. Also tax and regulatory event calls 16 Subsequent call dates, if applicable Optional call on 15/12/2023 and each fifth anniversary date thereafter Coupons / dividends 17 Fixed or floating dividend/coupon Fixed 18 Coupon rate and any related index 8.25% to 15/12/2018. Resets on 15/12/2018 and on every fifth anniversary date thereafter to five year US dollar swap rate plus 6.705% 19 Existence of a dividend stopper No 20a Fully discretionary, partially discretionary or mandatory (in terms of timing) Fully discretionary 20b Fully discretionary, partially discretionary or mandatory (in terms of amount) Fully discretionary 21 Existence of step up or other incentive to redeem No 22 Noncumulative or cumulative Noncumulative 23 Convertible or non-convertible Convertible 24 If convertible, conversion trigger(s) Fully loaded CET1 Ratio falls below 7% 25 If convertible, fully or partially Fully 26 If convertible, conversion rate USD 2.64 per conversion share 27 If convertible, mandatory or optional conversion Mandatory 28 If convertible, specify instrument type convertible into Common Equity Tier 1 - Ordinary shares 29 If convertible, specify issuer of instrument it converts into Barclays PLC 30 Write-down features No 31 If write-down, write-down trigger(s) N/A 32 If write-down, full or partial N/A 33 If write-down, permanent or temporary N/A 34 If temporary write-down, description of write-up mechanism N/A 35 Position in subordination hierarchy in liquidation (specify instrument type immediately senior to instrument) Dated Subordinated Debt 36 Non-compliant transitioned features No 37 If yes, specify non-compliant features N/A barclays.com/annualreport Barclays Pillar 3 disclosure - Terms and Conditions of Capital Resources I 4